Activity-Dependent Neuroprotective Protein Fragment 74-81, mouse, rat
≥97.0% (HPLC)
- Product Code: 77434
CAS:
211439-12-2
| Molecular Weight: | 824.92 g./mol | Molecular Formula: | C₃₆H₆₀N₁₀O₁₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD03787945 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
The peptide fragment 74-81 derived from Activity-Dependent Neuroprotective Protein (ADNP) is primarily studied for its neuroprotective properties. It is used in research to explore its potential in protecting neurons from damage caused by oxidative stress, inflammation, or other neurodegenerative conditions. This fragment is particularly of interest in studies related to Alzheimer's disease, autism spectrum disorders, and other neurological conditions where neuroprotection is crucial. Researchers utilize it to investigate its role in enhancing synaptic plasticity, promoting neuronal survival, and improving cognitive functions in animal models. Its application extends to preclinical studies aimed at developing therapeutic strategies for neurodegenerative diseases.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | £79.59 |
+
-
|
Activity-Dependent Neuroprotective Protein Fragment 74-81, mouse, rat
The peptide fragment 74-81 derived from Activity-Dependent Neuroprotective Protein (ADNP) is primarily studied for its neuroprotective properties. It is used in research to explore its potential in protecting neurons from damage caused by oxidative stress, inflammation, or other neurodegenerative conditions. This fragment is particularly of interest in studies related to Alzheimer's disease, autism spectrum disorders, and other neurological conditions where neuroprotection is crucial. Researchers utilize it to investigate its role in enhancing synaptic plasticity, promoting neuronal survival, and improving cognitive functions in animal models. Its application extends to preclinical studies aimed at developing therapeutic strategies for neurodegenerative diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :